News
SIBN
21.40
+4.90%
1.00
Why Did SI-Bone (SIBN) Surge Spike After Hours?
Benzinga · 1d ago
Wave of Insider Moves Rock SI-Bone as Top Executives Cash Out Shares
TipRanks · 1d ago
Weekly Report: what happened at SIBN last week (1229-0102)?
Weekly Report · 3d ago
Weekly Report: what happened at SIBN last week (1222-1226)?
Weekly Report · 12/29/2025 09:54
Weekly Report: what happened at SIBN last week (1215-1219)?
Weekly Report · 12/22/2025 09:54
SI-BONE SVP and Chief Legal Officer Michael A. Pisetsky Reports Disposal of Common Shares
Reuters · 12/19/2025 22:26
SI-BONE CFO Anshul Maheshwari Reports Disposal of Common Shares
Reuters · 12/19/2025 22:25
SI-BONE Is Maintained at Buy by Truist Securities
Dow Jones · 12/18/2025 16:09
SI-BONE Price Target Raised to $23.00/Share From $21.00 by Truist Securities
Dow Jones · 12/18/2025 16:09
Truist Securities Maintains Buy on SI-BONE, Raises Price Target to $23
Benzinga · 12/18/2025 15:58
SI-Bone price target raised to $23 from $21 at Truist
TipRanks · 12/18/2025 14:15
U.S. RESEARCH ROUNDUP-Autozone, Coursera, Lennar
Reuters · 12/18/2025 06:42
SI-BONE Price Target Raised to $27.00/Share From $26.00 by Canaccord Genuity
Dow Jones · 12/17/2025 20:33
SI-BONE Is Maintained at Buy by Canaccord Genuity
Dow Jones · 12/17/2025 20:33
Canaccord Genuity Maintains Buy on SI-BONE, Raises Price Target to $27
Benzinga · 12/17/2025 20:24
SI-Bone price target raised to $27 from $26 at Canaccord
TipRanks · 12/17/2025 12:30
SI-Bone (SIBN) Gets a Buy from Canaccord Genuity
TipRanks · 12/17/2025 12:09
U.S. RESEARCH ROUNDUP-Airbnb, Garrett Motion, Range Resources
Reuters · 12/17/2025 07:13
SI-BONE INC <SIBN.O>: CANACCORD GENUITY RAISES TARGET PRICE TO $27 FROM $26
Reuters · 12/17/2025 04:59
Accenture To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Tuesday
Benzinga · 12/16/2025 12:58
More
Webull provides a variety of real-time SIBN stock news. You can receive the latest news about Si-Bone through multiple platforms. This information may help you make smarter investment decisions.
About SIBN
SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants, and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.